118O Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: A randomised, phase III trial of the Gruppo Italiano Mammella
Lucia Del Mastro(Ospedale Policlinico San Martino), Paolo Bruzzi(Alleanza Contro il Cancro), Francesca Poggio(Ospedale Policlinico San Martino), Ornella Garrone(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Claudia Bighin(Azienda Ospedaliera S.Maria), Stefania Gori(Ospedale Sacro Cuore Don Calabria), G. Sanna(Azienda Ospedaliero Universitaria di Sassari), Mauro Mansutti(Ospedale Santa Maria della Misericordia di Udine), Giancarlo Bisagni, Antonio Frassoldati(Italian Oncology Group of Clinical Research), Riccardo Ponzone(Candiolo Cancer Institute), Carlo Barone(Institut d'Etudes Politiques de Paris), Sabino De Placido, Matteo Lambertini(Ospedale Policlinico San Martino), Ylenia Urracci, Silvia Mura(Ospedale SS. Annunziata), Andrea Michelotti(University of Pisa), Antonio Durando(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Francesco Cognetti(National Cancer Institute), Laura Amaducci(Ospedale degli Infermi)
Cited by 1
Related Papers
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
|The Lancet|2007|912
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
Cancer and fertility preservation: international recommendations from an expert meeting
|BMC Medicine|2016|779